California’s insulin initiative offers path for other state drug manufacturing efforts

Corporate businessmen working on tablet at office

In a new ‘Ideas and Opinions,’ authors from Johns Hopkins Bloomberg School of Public Health analyze California’s newly announced effort to manufacture insulin for its residents. The commentary is published in Annals of Internal Medicine.

Amazon’s new Kindle is a great addition to your library

Previous article

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations